Characteristics of nausea and its effects on quality of life in diabetic and idiopathic gastroparesis

Journal of Clinical Gastroenterology

Volumn 45, Issue 4, 2011, Pages 317-321

  Jaffe, Jane K ^a   Paladugu, Susmita ^a   Gaughan, John P ^b   Parkman, Henry P ^a  

^a TEMPLE UNIVERSITY HOSPITAL   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

gastroparesis; nausea; vomiting

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PATIENT REFERRAL; PRIORITY JOURNAL; QUALITY OF LIFE; SCINTIGRAPHY; SCORING SYSTEM; SHORT FORM 36; STOMACH EMPTYING; STOMACH PARESIS; STOMACH RADIOGRAPHY;

ADULT; DIABETES MELLITUS; FEMALE; GASTRIC EMPTYING; GASTROPARESIS; HUMANS; MALE; MIDDLE AGED; NAUSEA; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; VOMITING;

EID: 79952794884     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e3181eeb5e9     Document Type: Article

References (25)

1. Parkman HP, Hasler WL, Fisher RS. American gastroentero-logical association technical review on the diagnosis and treat-ment of gastroparesis. Gastroenterology. 2004;127:1592-1622. (Pubitemid 39457783)
2. Anaparthy R, Pehlivanov N, Grady J, et al. Gastroparesis and gastroparesis-like syndrome: response to therapy and its predictors. Dig Dis Sci. 2009;54:1003-1010.
3. Frank L, Kleinman L, Ganoczy D, et al. Upper gastrointest-inal symptoms in north america: prevalence and relationship to healthcare utilization and quality of life. Dig Dis Sci. 2000; 45:809-818. (Pubitemid 30186067)
4. Harrell SP, Studts JL, Dryden GW, et al. A novel classification scheme for gastroparesis based on predominant-symptom presentation. J Clin Gastroenterol. 2008;42:455-459. (Pubitemid 351572266)
5. Hoogerwerf WA, Pasricha PJ, Kalloo AN, et al. Pain: the overlooked symptom in gastroparesis. Am J Gastroenterol. 1999;94:1029-1033. (Pubitemid 29173623)
6. Hasler WL, Chey WD. Nausea and vomiting. Gastroentero logy. 2003;125:1860-1867. (Pubitemid 37500449)
7. Stapleton J, Wo JM. Current treatment of nausea and vomit-ing associated with gastroparesis: antiemetics, prokinetics, tricyclics. Gastrointest Endoscopy Clin N Am. 2009;19:57-72.
8. Gaddipati KV, Simonian HP, Dresge KM, et al. Abnormal ghrelin and pancreatic polypeptide responses in gastroparesis. Dig Dis Sci. 2006;51:1339-1346. (Pubitemid 44315799)
9. Maxton DG, Whorwell PJ. Functional bowel symptoms in diabetes\the role of autonomic neuropathy. Postgrad Med J. 1991;67:991-993.
10. Morrow GR. A patient report measure for the quantification of chemotherapy induced nausea and emesis: psychometric properties of the morrow assessment of nausea and emesis (MANE). Br J Cancer. 1992;66:S72-S74. (Pubitemid 23006183)
11. Morrow GR. The assessment of nausea and vomiting: past problems, current issues, and suggestions for future research. Cancer. 1984;53:2267-2280. (Pubitemid 14136880)
12. Melzack R, Rosberger MA, Hollingsworth ML, et al. New approaches to measuring nausea. Can Med Assoc J. 1985;133: 755-761.
13. Muth ER, Stern RM, Thayer JF, et al. Assessment of the multiple dimensions of nausea: the nausea profile (NP). J Psychosomatic Res. 1996;40:511-520. (Pubitemid 26174493)
14. Rentz AM, Kahrilas P, Stanghellini V, et al. Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res. 2004;13:1737-1749. (Pubitemid 41215253)
15. Revicki DA, Rentz AM, Dubois D, et al. Gastroparesis cardinal symptom index (GCSI): development and validation of a patient reported assessment of severity of gastroparesis symptoms. Qual Life Res. 2004;13:833-844. (Pubitemid 38509983)
16. De la Loge C, Trudeau E, Marquis P, et al. Cross-cultural development and validation of a patient self-administered questionnaire to assess quality of life in upper gastrointestinal disorders: the PAGI-QOL. Qual Life Res. 2004;13:1751-1762. (Pubitemid 41215254)
17. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31:247-263.
18. Tougas GH, Eaker EY, Abell TL, et al. Assessment of gastric emptying using a low fat meal: Establishment of international control values. Am J Gastroenterol. 2000;95:1456-1462. (Pubitemid 30396302)
19. Abell TL, Camilleri M, Donohoe K, et al. Consensus recommendations for gastric emptying scintigraphy. a joint report of the society of nuclear medicine and The American Neurogastroenterology and Motility Society. Am J Gastro-enterology. 2008;103:753-763. (Pubitemid 351405987)
20. Muth ER. Motion and space sickness: intestinal and auto-nomic correlates. Autono Neurosci: Basic Clin. 2006;129:58-66. (Pubitemid 44470860)
21. Hu S, Grant WF, Stern RM, et al. Motion sickness severity and physiological correlates during repeated exposure to a rotating optokinetic drum. Aviat Space Environ Med. 1991; 62:308-314.
22. Silver BJ, Rhodes JB, Schimke PN, et al. Bezoars: a complication of diabetic gastroparesis. J Kans Med Soc 1983; 84:249-250.
23. Horowitz M, Harding PE, Maddox AF, et al. Gastric and oesophageal emptying in insulin-dependent diabetes mellitus. J Gastroenterol Hepatol. 1986;1:97-113.
24. Horowitz M, Harding PE, Maddox AF, et al. Gastric and oesophageal emptying in patients with type 2 (non-insulin dependent) diabetes mellitus. Diabetologia. 1989;32:151-159. (Pubitemid 19117093)
25. Hasler WL, Coleski R, Chey WD, et al. Differences in intragastric pH in diabetic versus idiopathic gastroparesis: relation to degree of gastric retention. Am J Physiol Gastrointest Liver Physiol. 2008;294:G1384-G1391.